U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07258329) titled 'Screening for Intrapartum Fetal Compromise Using Placental Biomarkers' on Nov. 19.
Brief Summary: This study aims to investigate the association between placental markers (sFlt-1, PlGF, and the sFlt-1/PlGF ratio) and intrapartum fetal compromise, assessed on the basis of the cardiotocographic tracing.
Study Start Date: March 28
Study Type: OBSERVATIONAL
Condition:
Pregnant Women
Recruitment Status: RECRUITING
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Published by HT Digital Content Services with permission from Health Daily Digest....